These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18766166)

  • 1. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
    El-Akawi ZJ; Al-Hindawi FK; Bashir NA
    Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients.
    El-Akawi ZJ; Abu-Awad AM; Sharara AM; Khader Y
    Neuro Endocrinol Lett; 2010; 31(1):113-6. PubMed ID: 20150872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin phenotypes in patients with lung, prostate and breast cancer.
    El-Akawi ZJ; Al-Hindawi FK
    Saudi Med J; 2004 Feb; 25(2):186-9. PubMed ID: 14968215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.
    Micksche M; Kokron O
    Osterr Z Onkol; 1977; 3(5-6):116-9. PubMed ID: 67586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered carbohydrate content of alpha1-antitrypsin in patients with cancer.
    Rostenberg I; Guízar-Vázquez J; Peñaloza R
    J Natl Cancer Inst; 1978 Oct; 61(4):961-5. PubMed ID: 309009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relations between serum apha-antitrypsin level and neoplasms].
    Apicella C; Carniato A; Ippoliti F; Romano V; Tomai A; Ferrari S
    Arch Sci Med (Torino); 1976; 133(2):103-8. PubMed ID: 1087553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients.
    El-Akawi ZJ; Nusier MK; Zoughool FE
    Saudi Med J; 2006 Feb; 27(2):181-4. PubMed ID: 16501672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
    Kovcić V; Jelić S; Filipović I; Tomasević Z
    Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum A1-antitrypsin levels in prostate pathology].
    Dokrunova AA; Sokolova OS
    Urologiia; 2012; (5):77-80. PubMed ID: 23342621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease.
    Hauck EW; Hauptmann A; Haag SM; Bohnert A; Weidner W; Bein G; Hackstein H
    Eur Urol; 2004 Nov; 46(5):623-8; discussion 628. PubMed ID: 15474273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
    Pazdiora P; Svobodova S; Fuchsova R; Kucera R; Prazakova M; Vrzalova J; Narsanska A; Strakova M; Treskova I; Pecen L; Treska V; Holubec L; Pesek M; Finek J; Topolcan O
    Anticancer Res; 2011 Oct; 31(10):3619-21. PubMed ID: 21965787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
    Zelvyte I; Wallmark A; Piitulainen E; Westin U; Janciauskiene S
    Anticancer Res; 2004; 24(1):241-7. PubMed ID: 15015603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function and cancer risk: a prospective population study.
    Hellevik AI; Asvold BO; Bjøro T; Romundstad PR; Nilsen TI; Vatten LJ
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):570-4. PubMed ID: 19155436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the clinical significance of antigenic and functional levels of α1-proteinase inhibitor (α1-Pi) in infiltrating ductal breast carcinomas.
    Anes AB; Nasr HB; Hammann P; Kuhn L; Trimeche M; Hamrita B; Bougmiza I; Chaieb A; Khairi H; Chahed K
    Clin Biochem; 2012 Nov; 45(16-17):1421-31. PubMed ID: 22841602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [alpha 1-proteinase inhibitor in breast cancer].
    Demidov VP; Iakubovskaia RI; Karmakova TA; Avdeev GI; Komissarov AB; Sorokin EE; Kotova TS
    Vopr Onkol; 1990; 36(1):23-9. PubMed ID: 2106187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfa-antitrypsin increase in lung cancer.
    Daddi G; Mancini PA; Parola D; Contini A
    Boll Ist Sieroter Milan; 1976; 55(6):510-2. PubMed ID: 1088073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assay of "pregnancy alpha 2 glycoprotein" in the serum of prostatic cancer patients and changes during estrogen therapy].
    Lanson Y; Lanson M; Gutman N; Muh JP
    J Urol Nephrol (Paris); 1979 Jun; 85(6):399-407. PubMed ID: 90738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.